Arterial hypertension (HA) is the leading cause of cerebral vascular accidents (strokes) in France and often sets in very early.
But it’s not inevitable. An Australian study has shown that even without restrictive treatment and without medication, simply taking Coenzyme Q10 as a food supplement can significantly lower blood pressure.
In order better to assess its capability, a team led by Dr Franklin L. Rosenfeldt of Melbourne compiled 12 clinical trials. All related to the role of this natural nutrient in regulating blood pressure. The results are quite conclusive. One supplement of 100 to 120 mg of Coenzyme Q10 per day can lower both systolic and diastolic pressure. And it can do this without any significant secondary effect, Dr Rosenfeldt reports. Better still, this approach has proved effective as a complement to conventional treatment for those suffering from unbalanced blood pressure.
In fact, Coenzyme Q10 acts both as a preventive and as an adjuvant to conventional treatment. Exactly right, according to Professor Svend Aage Mortensen of Copenhagen University Hospital. Professor Mortensen is one of Europe’s leading cardiologists in the use of Coenzyme Q10. However, he also points out that supplements must be at least 100 to 200 mg per day or the benefits are not the same.
Your doctor will be able to guide you in choosing the right supplement for you. It’s also important to remember that as CoQ10 is liposoluble the complement you take with it should be oil-based rather than in powder or tablet form. This combination will ensure that the body is able to assimilate it properly.
Source : Journal of Human hypertension (2007), 21, 297-306 ; interview Pr Svend Aage Mortensen, l’Hôpital Universitaire de Copenhague (Danemark), 24 november 2008
Are you a journalist? Find out more by subscribing to our professional website: agence-destinationsante.com
© 1996-2013 Destination Santé SAS - All Rights Reserved. None of the information contained on this server can be reproduced or redistributed without the prior written consent of Destination Santé. Offenders will be liable to the penalties provided for in Articles L 122-4 and L 335-3 of the Code of Intellectual Property, up to two years imprisonment and a 150,000 euros fine.